during a mean follow-up period of 18 to 24 months , there were no significant differences between the two groups in number of deaths , renal or extrarenal manifestations of disease , serum complement levels , dna antibodies , antinuclear antibody titers , lupus erythematosus cells , or coombs ' antibodies .
C0229671
serum
C0009498
complement